| 251 |
Evaluation of some lysosomal hydrolases and membrane marker enzymes in malignant ovariant tissues. |
1999 |
| 252 |
Soluble Interleukin-2 Receptor (sIL-2), Tumor Necrosis Factor Alpha (TNF-α)and its Receptor as Prognostic Markers in Non-Hodgkin,s Lymphoma. |
1999 |
| 253 |
CLINICAL EVALUATION OF CONVENTIONAL VERSUS HYPERFRACTIONATED RADIOTHERAPY IN THE LOCAL CONTROL OF ADVANCED SQUAMOUS CELL CARCINOMA (T3,T4) OF THE LARYNX IN UPPER EGYPT |
1994 |
| 254 |
CLINICAL EVALUATION OF CONVENTIONAL VERSUS HYPERFRACTIONATED RADIOTHERAPY IN THE LOCAL CONTROL OF ADVANCED SQUAMOUS CELL CARCINOMA (T3,T4) OF THE LARYNX IN UPPER EGYPT |
1994 |
| 255 |
CLINICAL EVALUATION OF CONVENTIONAL VERSUS HYPERFRACTIONATED RADIOTHERAPY IN THE LOCAL CONTROL OF ADVANCED SQUAMOUS CELL CARCINOMA(T3, T4) OF THE LARYNX IN UPPER EGYPT |
1994 |
| 256 |
CLINICAL EVALUATION OF CONVENTIONAL VERSUS HYPERFRACTIONATED RADIOTHERAPY IN THE LOCAL CONTROL OF ADVANCED SQUAMOUS CELL CARCINOMA(T3, T4) OF THE LARYNX IN UPPER EGYPT |
1994 |
| 257 |
AB1189 BOTULINUM TOXIN TYPE A OR SELECTIVE GENICULAR PULSED RADIOFREQUENCY FOR TREATING ADVANCED KNEE OSTEOARTHRITIS |
|
| 258 |
Analysis of the association between the Slit2 biomarker and systemic lupus erythematosus |
|
| 259 |
Clinical utility of serum Galactin-9 in evaluation of systemic lupus erythematosus patients |
|
| 260 |
Influence of rheumatoid arthritis and systemic lupus erythematosus on quality of life of female patients |
|
هل لديك سؤال ؟
